Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBIAT (2017 - 2020)

Historic EBIAT for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.3 million.

  • Cogent Biosciences' EBIAT fell 59360.03% to -$11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$74.8 million, marking a year-over-year decrease of 13500.14%. This contributed to the annual value of -$328.9 million for FY2025, which is N/A changed from last year.
  • Cogent Biosciences' EBIAT amounted to -$11.3 million in Q4 2020, which was down 59360.03% from -$50.0 million recorded in Q3 2020.
  • Over the past 5 years, Cogent Biosciences' EBIAT peaked at $2.3 million during Q4 2019, and registered a low of -$50.0 million during Q3 2020.
  • For the 4-year period, Cogent Biosciences' EBIAT averaged around -$10.4 million, with its median value being -$8.0 million (2018).
  • As far as peak fluctuations go, Cogent Biosciences' EBIAT surged by 12669.07% in 2019, and later tumbled by 59360.03% in 2020.
  • Over the past 4 years, Cogent Biosciences' EBIAT (Quarter) stood at -$6.7 million in 2017, then decreased by 28.64% to -$8.6 million in 2018, then skyrocketed by 126.69% to $2.3 million in 2019, then tumbled by 593.6% to -$11.3 million in 2020.
  • Its last three reported values are -$11.3 million in Q4 2020, -$50.0 million for Q3 2020, and -$7.4 million during Q2 2020.